Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) posted a 36% decline year-on-year in its profits during the third quarter of 2016, according to a bourse statement.
Profits reached AED 23.4 million ($6.4 million) in Q3-16, compared to AED 36.5 million ($10 million) in Q3-15.
In the first nine months of 2016, profits declined 15.34% to AED 157.2 million from AED 185.7 million in the prior-year period.
